Loading...

Follow The New Prostate Cancer InfoLink on Feedspot

Continue with Google
Continue with Facebook
or

Valid

A couple of weeks ago (see here) we had first told you about the launch of the new PCa Social Network PLUS app that allows mobile access to a new social netowrk (and a clinical trial of its effects) for men with prostate cancer. We are delighted to be able to tell you that there […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
It will come as no surprise to the well-informed that if you are taking a 5-alpha-reductase inhibitor (a 5-ARI) like dutasteride or finasteride for benign prostatic hyperplasia (BPH), it significantly lowers your “normal” PSA level (to about half the actual value). However, it may come as something of a shock to learn that, as a […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
The roles of patients, patient advocates, and other members of the public in decision-making about the research that is funded by NIH and other agencies here in America is sadly somewhat limited, although it is great deal more apparent and evident that it was 20 or 30 years ago. The NIH’s Office of Behavioral and […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
We have noted several times in the past that, at least to date, compared to the results shown by the PD-1 and PD-L1 checkpoint inhibitors in the treatment of cancers like lung cancer, kidney cancer, and melanoma, there has been little evidence of the value of these agents in the treatment of advanced prostate cancer. […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
The first iteration of the Advanced Prostate Cancer Consensus Conference (APCCC) was held in St. Gallen, Switzerland, in 2017, and the second iteration is upcoming in late August this year — this time in Basel. Your sitemaster has been invited to attend this second meeting and has managed to scrape up the funds to pay […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
The American Society of Clinical Oncology (ASCO) has just released the abstracts of papers to be presented at the upcoming annual meeting in Chicago, starting on Friday, May 31. For those interested in looking through these abstracts themselves, there appear to be about 475 that deal with prostate cancer. You can review these abstracts if […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
We have known for many years (certainly at least 20) that the presence of abnormal numbers of chromosomes (aneuploidy) in prostate cancer tumor cells is a risk factor for more serious forms of prostate cancer. A newly published paper by Stopsack et al. in the Proceedings of the National Academy of Sciences or PNAS now […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
The results of the 1,125-patient, randomized, double-blind ENZAMET trial are to be reported in a late-breaking abstract at the upcoming annual meeting of the American Society for Clinical Oncology (ASCO) in Chicago. We can reasonably assume that the sponsors of this trial — the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Back in February this year we had told you about the development of a new type of social network that would (a) allow men to share information about their prostate cancer with each other and (b) collect that data to evaluate whether such networking improved patients’ quality of life. So, as of this week, the […]
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
The issue of spontaneous remission of low-risk forms of prostate cancer came up yesterday during a meeting of Prostate Cancer International’s Active Surveillance Virtual Support Group (ASVSG). Your sitemaster is aware of just one reported case of spontaneous remission in a high-risk form of prostate cancer. In the report of this case, Lee et al. […]
Read Full Article

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview